Report: Financing a barrier to European biotechs

04/20/2005 | Cordis

The report from biotechnology consultants Critical I compares the state of the European biotechnology industry with that of the U.S., and concludes Europe has much to do to catch up with the U.S., citing a lack of access to financing as the largest obstacle European companies face. The report says the financing problem is most acute later in the business cycle, leading many companies to fold after three to five years.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC